Sumatriptan Succinate Tablet, Film Coated
Product Images NDC 0378-5632
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 0378-5632). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Image 02)
Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Image 03)
Sumatriptan Tablets 25 mg Bottle Label (Image 04)
Sumatriptan Tablets 50 mg Bottle Label (Image 05)
Sumatriptan Tablets 100 mg Bottle Label (Image 06)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.